Managed care's clinical and economic impact on patients with type II diabetes in France: A controlled population-based study

International Journal of Health Care Quality Assurance

Volumn 21, Issue 3, 2008, Pages 297-307

  Boyer, Laurent ^a   François, Patrice ^a   Fourny, Magali ^a   Ohrond, Céline ^b   Chanut, Charles ^c   Labarère, José ^a   Auquier, Pascal ^d  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Réseau de Prise en Charge des Patients Diabétiques de Type II Diabaix   (France)

^c Direction Regionale du Service Medical PACA et Corse   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Diabetes; Economics; France; Health services; Medical management; Patient care

Indexed keywords

ANTIDIABETIC AGENT;

AGED; ARTICLE; COST BENEFIT ANALYSIS; DISEASE MANAGEMENT; ECONOMICS; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION AND MANAGEMENT; PROSPECTIVE STUDY;

AGED; BLOOD GLUCOSE; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; FRANCE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE;

EID: 43049135554     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526860810868238     Document Type: Article

References (18)

1. Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES) (1999), Recommandations pour la pratique clinique. Suivi du patient diabétique de type 2 à l'exclusion du suivi des complications, ANAES, Paris, 148 pp..
2. Bland, J.M. and Altman, D.G. (1996), "The use of transformation when comparing two means", British Medical Journal, Vol. 312 No. 7039, p. 1153.
3. Boyer, L., Koch, F.X., Fourny, M., Weil, G. and Francois, P. (in press), "The evaluation feasibility study of a healthcare network for the management of severely head-injured patients", Santé Publique (in press).
4. Boyer, L., Ohrond, C., Fortanier, C., Fourny, M., Horte, C., Loï, R., Chanut, C. and Francois, P. (forthcoming), "Qualité et coût de la prise en charge des patients diabétiques de type II dans la région Provence Alpes Côte d'Azur: impact d'une prise en charge coordonnée dans un réseau de santé", Revue médicale de l'assurance maladie (submitted for publication).
5. Boyer, L., Fortanier, C., Antoniotti, S., Tonnaire, G., Giusiano, B., Horte, C., Chanut, C., Carles, M., Fourny, M., Francois, P. and Auquier, P. (2005), "A pragmatic tool to assess health networks", Journal d'Economie Médicale, Vol. 23 Nos 7-8, pp. 425-37.
6. Brindel, P., Fagot-Campagna, A., Petit, C., Coliche, V., Isnard, D., Simon, M., Varroud-Vial, M. and Weill, A. (2002), "ENTRED: lancement d'une étude sur un échantillon national de 10,000 personnes diabétiques traitées", Bulletin Epidémiologique Hebdomadaire, Nos 20-21, pp. 88-9.
7. CDC Diabetes Cost-Effectiveness Group (2002), "Cost-effectiveness of intensive glycemic control, intensified hypertension control and serum control level reduction for type 2 diabetes", American Medical Association Journal, Vol. 287 No. 19, pp. 2542-51.
8. Davies, H.T. and Crombie, I.K. (1995), "Assessing the quality of care", British Medical Journal, Vol. 311 No. 7008, p. 766.
9. Eliasson, B., Cederholm, J., Nilsson, P. and Gudbjörnsdottir, S. (2005), "The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996-2003", Diabetic Medicine, Vol. 22 No. 10, pp. 1420-6 (for the Steering Committee of the Swedish National Diabetes Register).
10. Fortanier, C., Boyer, L., Tonnaire, G., Chanut, C., Francois, P. and Auquier, P. (2005), "Health networks and their economic consequences: what evaluation?", Journal d'Economie Médicale, Vol. 23 Nos 7-8, pp. 415-24.
11. Journal Officiel (2002), "Loi no. 2002.303 du 4 mars. Relative aux droits des malades et à la qualité du système de santé", 54, 5 March.
12. Kirkwood, B. (2004), "Making public health interventions more evidence based", British Medical Journal, Vol. 328 No. 7446, pp. 966-7.
13. Lachenbruch, P.A. (2001), "Comparisons of two-part models with competitors", Statistics in Medicine, Vol. 20 No. 8, pp. 1215-34.
14. Passa, P. (2002), "Diabetes trends in Europe", Diabetes/Metabolism Research and Reviews, Vol. 18, S3, pp. S3-S8.
15. Renders, C.M., Valk, G.D., Griffin, S.J., Wagner, E.H., Van Eijk, J.T. and Assendelft, W.J.J. (2001), "Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review", Diabetes Care, Vol. 24 No. 10, pp. 1821-33.
16. Ricordeau, P., Weill, A., Vallier, N., Bourrel, R., Schwartz, D., Guilhot, J., Fender, P. and Allemand, H. (2003), "The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?", Diabetes & Metabolism, Vol. 29 No. 5, pp. 497-504.
17. Skylers, J.S. and Oddo, C. (2002), "Diabetes trends in the USA", Diabetes/Metabolism Research and Reviews, Vol. 18 No. S3, pp. S21-6.
18. Weill, A., Ricordeau, P., Vallier, N., Bourrel, R., Fender, P. and Allemand, H. (2000), "Modalities of follow-up on non-insulin treated diabetics treated in metropolitan France in 1998", Diabetes & Metabolism, Vol. 26 No. 6, pp. 39-48.